Core Insights - The IIT study aims to explore the clinical efficacy and safety of the ZAP-X radiosurgery robot for brain metastases patients, marking a significant advancement in precision radiotherapy for brain tumors [1][3][4] Group 1: Industry Context - Over 1.5 million new cases of brain metastases are reported annually in China, making it the most prevalent type of brain tumor [3] - Brain metastases are secondary tumors formed when cancer cells spread from primary sites (such as lungs or breasts) to the brain, indicating advanced cancer stages with poor prognosis [3] Group 2: Research Details - The IIT study is guided by the Chinese Intracranial Metastasis Collaboration Group and is designed by clinical researchers rather than pharmaceutical or medical device companies [3][4] - The ZAP-X device, developed by Professor John Adler, features a unique dual-rotating spherical structure that generates thousands of non-coplanar beams, allowing for precise targeting of tumor areas while protecting surrounding healthy brain tissue [3][4] Group 3: Clinical Goals - The study is expected to be the largest prospective research on ZAP-X treatment for brain metastases, aiming to establish consensus on precision radiotherapy and improve the median survival time of 200,000 to 500,000 brain metastases patients by 1 to 2 months [4] - The collaboration between Xuanwu Hospital and Baiyang Medical represents a significant step in integrating ZAP-X into China's clinical research framework, enhancing the availability of precision radiotherapy centers for a broader patient base [4]
宣武医院启动脑转移瘤精准放疗临床研究